Please login to the form below

Not currently logged in
Email:
Password:

Tretten

This page shows the latest Tretten news and features for those working in and with pharma, biotech and healthcare.

US approval for Novo's Factor XIII drug Tretten

US approval for Novo's Factor XIII drug Tretten

Study findings demonstrated that monthly treatment with Tretten prevented bleeding in 90 per cent of patients, with no evidence of abnormal clotting. ... Novo Nordisk said Tretten is expected to be launched in the US early next year.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics